| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 04/29/2009 | EP2051964A2 Fatty acid amide hydrolase inhibitors |
| 04/29/2009 | EP1558565B1 Halogenated selective androgen receptor modulators and methods of use thereof |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/23/2009 | WO2009051718A2 Calcium receptor modulating agents |
| 04/23/2009 | WO2009049961A2 New no-donor aspirin derivatives |
| 04/23/2009 | US20090105315 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists |
| 04/23/2009 | CA2702950A1 Methods and compounds for modulating cannabinoid activity |
| 04/23/2009 | CA2702946A1 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| 04/23/2009 | CA2701792A1 Calcium receptor modulating agents |
| 04/23/2009 | CA2700243A1 New no-donor aspirin derivatives |
| 04/22/2009 | EP1585518A4 Peptide deformylase inhibitors |
| 04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
| 04/21/2009 | US7521480 Such as 2-[3-(3-Bromo-phenyl)-ureido]-4-chloro-5-methyl-benzenesulfonic acid which is selective and non-competitive antagonist of ionotropic GluR5 receptor |
| 04/15/2009 | EP2046746A2 Chemical compounds |
| 04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 04/09/2009 | WO2009043890A1 Oxadiazole diaryl compounds |
| 04/09/2009 | US20090091234 Room temperature molten salt and display element |
| 04/09/2009 | CA2696829A1 Oxadiazole diaryl compounds |
| 04/08/2009 | CN100475795C Heterocyclic compounds useful as nurr-1 activators |
| 04/07/2009 | CA2276278C Amine compounds, their production and use |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/02/2009 | WO2009041972A1 Antibacterial compounds and methods of using same |
| 04/02/2009 | WO2009040507A1 Substituted benamidines as antibacterial agents |
| 04/02/2009 | US20090088570 Organic electroluminescent device |
| 04/01/2009 | EP2041101A1 Crystalline form of (trans-4- [ ( { 5- [ (3, 4 -di fluorophenyl) amino]-1,3, 4-oxadiazol-2-yl}carbonyl) amino]ph enyl } cyclohexyl) acetic acid |
| 04/01/2009 | EP2041100A1 Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase |
| 04/01/2009 | EP2041099A1 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors |
| 03/31/2009 | US7511149 Using ruthenium tetraoxide and alkali metal permanganate |
| 03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 03/26/2009 | US20090082393 New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them |
| 03/26/2009 | US20090079343 Organic electroluminescent device |
| 03/25/2009 | EP2039682A1 Salts for adding angiotensin conversion enzyme inhibitors to NO-donor acids, method of preparing same and pharmaceutical compositions containing them |
| 03/25/2009 | CN101391973A Salts for adding angiotensin conversion enzyme inhibitors to no-donor acids, method of preparing same and pharmaceutical compositions containing them |
| 03/24/2009 | US7507832 Triazole PPAR modulators |
| 03/24/2009 | US7507757 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/19/2009 | WO2009034396A2 Method and means relating to multiple herbicide resistance in plants |
| 03/19/2009 | US20090076113 Biphenylcarboxamides for controlling micro-organisms |
| 03/19/2009 | CA2737047A1 Method and means relating to multiple herbicide resistance in plants |
| 03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
| 03/12/2009 | WO2008079836A4 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 03/12/2009 | US20090069391 such as N-hydroxy-6-{1-[(4-methoxybenzyl)amino]-2-[(4-methoxyphenyl)amino]-2-oxoethyl}-1-benzothiophene-2-carboxamide, used to treat cancer, tumors, neurodegenerative, autoimmune, allergic and inflammatory diseases, and as histone deacetylase inhibitors |
| 03/12/2009 | US20090068378 Discotic nematic material, composition, retardation plate, elliptically-polarizing plate and compound |
| 03/12/2009 | US20090066245 Material for light-emitting element and light emitting element |
| 03/11/2009 | EP2032547A1 Compounds for the inhibition of dgat1 activity |
| 03/11/2009 | CN101384567A Diphenylurea derivatives and their use as chloride channel blockers or BKcA channel modulators |
| 03/11/2009 | CN101384566A Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists |
| 03/11/2009 | CN101384565A Substituted oxadiazole derivatives and their use as opioid receptor ligands |
| 03/11/2009 | CN101384170A Malononitrile compounds |
| 03/05/2009 | US20090062340 Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 03/04/2009 | EP0869974B1 Compounds with growth hormone releasing properties |
| 03/04/2009 | CN101378744A Oxadiazole compounds as urokinase inhibitors |
| 03/04/2009 | CN100465168C An oxdiazole derivative and an application thereof in electroluminescent materials |
| 03/03/2009 | US7498436 Substituted hydroxyethylamines |
| 02/26/2009 | US20090054658 Liquid Crystal Compound, Liquid Crystal Composition, Thin Film and Liquid Crystal Display |
| 02/26/2009 | US20090054435 Phenoxyalkanoic Acid Compound |
| 02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 02/26/2009 | US20090053328 Nitric Oxide Enhancing Glutamic Acid Compounds, Compositions and Methods of Use |
| 02/25/2009 | CN101374821A 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as S1P1 receptor agonists, immunosuppresssive and anti-inflammatory agents |
| 02/25/2009 | CN101374804A Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
| 02/19/2009 | WO2009023854A1 Bicyclic sphingosine 1-phosphate analogs |
| 02/19/2009 | WO2008157407A3 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia |
| 02/19/2009 | US20090048445 Method of Synthesizing Quinoxaline Derivative by Microwave Irradiation |
| 02/19/2009 | US20090048311 Compostions and Methods for Controlling Nematodes |
| 02/19/2009 | US20090048310 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048219 Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/19/2009 | CA2696488A1 Bicyclic sphingosine 1-phosphate analogs |
| 02/12/2009 | US20090042955 Bicyclic sphingosine 1-phosphate analogs |
| 02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
| 02/12/2009 | US20090042926 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 02/12/2009 | US20090042772 Compounds and methods of treating insulin resistance and cardiomyopathy |
| 02/11/2009 | EP2021338A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof |
| 02/11/2009 | EP2021331A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
| 02/05/2009 | US20090036451 Chemical inducers of neurogenesis |
| 02/05/2009 | US20090036450 Pyrazole compounds and use thereof |
| 02/04/2009 | EP1824817B1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 02/04/2009 | EP1565422B1 Vitamin d receptor modulators |
| 01/29/2009 | WO2009013360A1 Novel fluorescent derivatives of polyamine, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumours |
| 01/29/2009 | US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | CA2694474A1 Novel fluorescent derivatives of polyamine, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumours |
| 01/27/2009 | US7482465 Indol derivatives and their use as 5-HT ligands |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482448 Compounds and compositions as cathepsin inhibitors |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/15/2009 | WO2009008748A1 Pyrazolo[1,5-a]pyridines and their use in cancer therapy |
| 01/15/2009 | WO2008079836A3 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 01/15/2009 | US20090018172 DIPHENYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS OR BKCa CHANNEL MODULATORS |
| 01/15/2009 | US20090018058 Vitamin D Receptor Modulators |
| 01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
| 01/15/2009 | US20090015144 Fluoranthene compound, organic electroluminescence device using the same, and solution containing organic electroluminescence material |
| 01/15/2009 | CA2692653A1 Pyrazolo[1,5-.alpha.]pyridines and their use in cancer therapy |
| 01/14/2009 | EP2014653A1 Novel dicarboxylic acid derivatives as S1P1 receptor agonists |
| 01/14/2009 | EP2013190A2 SYNTHESIS OF 5-ß-KETO-1,2,4-OXADIAZOLES AND CONVERSION OF 5-ß-KETO-1,2,4-OXADIAZOLES TO N-PYRAZOLYL AMIDOXIMES |
| 01/14/2009 | EP1331221B1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 01/14/2009 | CN101346360A Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/08/2009 | WO2009005076A1 Amide compound |
| 01/08/2009 | WO2009004990A1 Fp receptor agonist |